EATG » Access to hepatitis C testing and treatment for people who inject drugs and people in prisons — a global perspective

Access to hepatitis C testing and treatment for people who inject drugs and people in prisons — a global perspective

The World Health Organization (WHO) released a policy brief on access to HCV testing and treatment for people who inject drugs and for people in prisons (April 2019).

Overview

WHO estimates that 71 million people worldwide were chronically infected with hepatitis C virus (HCV) in 2017. Globally, 23% of new HCV infections and one in three HCV deaths are attributable to injecting drug use (PWID). HCV is also a major concern for people detained in prisons and other closed settings – available data demonstrate that one in four detainees are HCV positive.

The policy brief highlights the current landscape of country hepatitis policies for harm reduction and HCV testing and treatment in PWID and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis, 2016-2021 into national plans, and provides a summary of the enablers and barriers to HCV testing and treatment in these populations.

Download the policy brief here.


 

 

Source:
WHO
News categories: Hepatitis, Key populations